Sitemap

EU Expects First COVID Vaccine Application In Coming Days

CorD Recommends

Belgrade Hotel Union Sold for €6.2 Million

Hotel Union, a historic landmark in Belgrade,...

Thousands of Tons of Frozen Water Found on Mars’ Volcano Summit

In a groundbreaking study published in the...

More People Opting Out of News Consumption Due to Content

The latest research shows that an increasing...

EU Ambassadors Reach Agreement to Open Accession Talks with Ukraine and Moldova

EU ambassadors have reached a preliminary agreement...

Finland Leads EU in Uranium Extraction

In a pioneering move within the European Union, Finnish mining and chemical company Terrafame has begun extracting uranium, as...

World’s Oldest Liquid Wine Found in Roman Tomb in Spain

The world’s oldest wine in liquid form has been discovered in a Roman tomb, boasting a reddish-brown hue due...

Mickoski Proposes New Government for North Macedonia

Hristijan Mickoski, leader of VMRO-DPMNE and the designated Prime Minister of North Macedonia, has formally submitted his proposed cabinet...

King Frederick X Inaugurates First Section of Undersea Tunnel Connecting Denmark and Germany

King Frederick X of Denmark has inaugurated the first segment of the ambitious 18-kilometre Fehmarn Belt tunnel beneath the...

Belgrade Hotel Union Sold for €6.2 Million

Hotel Union, a historic landmark in Belgrade, has been sold for 727 million dinars (€6.2 million) at a public...

The European Medicines Agency did not name the company it expects to file the application. However, EU leaders hope a vaccine will be available before the end of the year.

The first application for marketing approval of a COVID-19 vaccine in the European Union should arrive in the next few days, according to the European Medicines Agency (EMA).

The drug watchdog did not identify the drugmaker expected to file, however partners Pfizer and BioNTEch are the most advanced in the regulatory approval process. A total of three drugmakers have published late-stage trial data for their respective coronavirus vaccine candidates, including US firm Moderna, and a British partnership between AstraZeneca and Oxford University.

The Pfizer-BioNTech collaboration has already applied for approval in the US, and the UK has asked its medical regulator to assess the vaccine.

Researchers on the US-German vaccine should enjoy a speedy approval process, as they have been allowed to submit data in real-time to the EMA, without waiting for studies to conclude.

The EMA earlier acknowledged it was trying “to speed up” the evaluation process, but said it was “ensuring the same high regulatory standards for quality, safety and efficacy” as for any other drug.

EMA told the AFP news agency that it could approve the first COVID-19 vaccines by the end of the year. Many European countries, including France, Spain and Italy, have based their immunization plans on that basis.

German Chancellor Angela Merkel told lawmakers Thursday that a vaccine may become available before the end of the year.

In the US, if the Food and Drug Administration (FDA) approves accelarated rollout, vaccination efforts may start as early as mid-December.

Related

US Pharma Firm Moderna Says Its COVID-19 Vaccine Is 94.5% Effective

Moderna said that Phase 3 stage analysis suggested its coronavirus vaccine could prevent COVID-19. The news comes a week after Pfizer and German drug-maker...

Oxford Covid Vaccine Works In All Ages, Trials Suggest

Covid vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups One of the world’s leading Covid-19 experimental vaccines produces an...

Vaccination rollout

In China, medical authorities have already begun immunizing high-risk patients. In Russia, two vaccines have been validated for use before the final phase of clinical trials had started.

The candidates that have passed trials all claim more than 90% effiacy, but their results have not yet been backed up by by publication in peer-reviewed journals, which can usually take months.

Price and logistics will also factor in the success of the vaccines. AstraZeneca’s double dose is the cheapest, costing about €2.5 ($3) per dose and requires just a normal fridge temperature. Moderna’s vaccine must be kept at -20 degrees Celsius (-4 Farenheit), while Pfizer’s must be kept at -70C (-94 Farenheit).

Source:  Deutsche Welle

Related Articles

Finland Leads EU in Uranium Extraction

In a pioneering move within the European Union, Finnish mining and chemical company Terrafame has begun extracting uranium, as announced by local media. The...

EU Ambassadors Reach Agreement to Open Accession Talks with Ukraine and Moldova

EU ambassadors have reached a preliminary agreement to open accession talks with Ukraine and Moldova, according to an announcement from Brussels. Belgium, currently holding the...

Chinese Authorities Use Artificial Rain to Quell Major Forest Fire

In an innovative approach to firefighting, authorities in China's northern Shanxi province have managed to extinguish a significant forest fire by inducing artificial rain...

Slovenia Achieves Top Ten Status in Global Peace Index for 2024

Slovenia has distinguished itself as one of the world's most peaceful nations, securing a spot in the top ten of the 2024 Global Peace...

EU and Serbia Strengthen Bonds Through Cultural Heritage Initiatives

The European Union is intensifying its cultural engagement in Serbia, as highlighted at a panel discussion in Užice, part of the "Europe is Our...

European Centrist Parties Retain Majority in New EU Parliament Session

According to preliminary results from the European Parliament elections, the European People's Party (EPP), Social Democrats (S&D), and Liberals (Renew) will maintain a majority...

German Voters Dominate, Malta Least Represented in Upcoming European Parliament Elections

As the 2024 European Parliament elections draw near, set to take place from 6 to 9 June, Eurostat has requested national statistical institutes across...

Jakob Granit, Director General of the Swedish International Development Cooperation Agency (SIDA)

Only Inclusive Societies can Grow Sustainably

Inclusiveness, equity, gender balance and respect for nature represent the core values woven into all SIDA-supported projects. In striving to foster a society that...